Literature DB >> 12233884

Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis.

Elisabeth Dion1, Patrick Cherin, Christine Payan, Jean-Charles Fournet, Thomas Papo, Thierry Maisonobe, Eric Auberton, Olivier Chosidow, Pierre Godeau, Jean-Charles Piette, Serge Herson, Philippe Grenier.   

Abstract

OBJECTIVE: To develop diagnostic imaging criteria for polymyositis (PM) and sporadic inclusion body myositis (sIBM).
METHODS: We investigated 220 patients with suspected inflammatory myopathies by magnetic resonance imaging (MRI). Findings were compared with the results of clinical and biological examinations and muscle biopsy. PM and IBM were diagnosed in 25 patients each. Quantitative and qualitative MRI analysis of the 3 muscle groups of the 2 thighs included fatty infiltration, atrophy, inflammation, and the type and distribution of the lesions.
RESULTS: MRI was abnormal in all patients. Fatty infiltration and atrophy were more frequent in patients with sIBM (p < 0.05). Inflammation as the sole abnormality was preferentially encountered in PM (p = 0.05). Widespread abnormalities were more frequent in sIBM (p < 0.01). Abnormalities in PM tended to be distributed along the fascia. Involvement of the anterior group, an asymmetrical distribution, and a distal predominance were all more frequent in sIBM (p < 0.001).
CONCLUSION: Despite some overlap in MRI findings between the 2 diseases, MRI was useful for distinguishing PM from sIBM.

Entities:  

Mesh:

Year:  2002        PMID: 12233884

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  20 in total

Review 1.  Imaging and skeletal muscle disease.

Authors:  Nancy J Olsen; Jing Qi; Jane H Park
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

2.  Diagnosis and treatment of the idiopathic inflammatory myopathies.

Authors:  David J Gazeley; Mary E Cronin
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-12       Impact factor: 5.346

Review 3.  Ischiofemoral impingement syndrome: a meta-analysis.

Authors:  Adam D Singer; Ty K Subhawong; Jean Jose; Jonathan Tresley; Paul D Clifford
Journal:  Skeletal Radiol       Date:  2015-02-13       Impact factor: 2.199

4.  Morphologic imaging in muscular dystrophies and inflammatory myopathies.

Authors:  Adrian Degardin; David Morillon; Arnaud Lacour; Anne Cotten; Patrick Vermersch; Tanya Stojkovic
Journal:  Skeletal Radiol       Date:  2010-05-07       Impact factor: 2.199

5.  Contrast-enhanced ultrasound in dermatomyositis- and polymyositis.

Authors:  Marc-André Weber; Uta Jappe; Marco Essig; Martin Krix; Carina Ittrich; Hagen B Huttner; B Hagen Huttner; Uta Meyding-Lamadé; Marius Hartmann; Hans-Ulrich Kauczor; Stefan Delorme
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

Review 6.  Role of MRI in diagnosis and management of idiopathic inflammatory myopathies.

Authors:  Britta Maurer; Ulrich A Walker
Journal:  Curr Rheumatol Rep       Date:  2015-11       Impact factor: 4.592

7.  Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.

Authors:  Iago Pinal-Fernandez; Maria Casal-Dominguez; John A Carrino; Arash H Lahouti; Pari Basharat; Jemima Albayda; Julie J Paik; Shivani Ahlawat; Sonye K Danoff; Thomas E Lloyd; Andrew L Mammen; Lisa Christopher-Stine
Journal:  Ann Rheum Dis       Date:  2016-09-20       Impact factor: 19.103

Review 8.  [Inflammatory myopathies].

Authors:  B Schoser
Journal:  Z Rheumatol       Date:  2009-10       Impact factor: 1.372

Review 9.  Inclusion body myositis: clinical features and pathogenesis.

Authors:  Steven A Greenberg
Journal:  Nat Rev Rheumatol       Date:  2019-05       Impact factor: 20.543

10.  Texture analysis of muscle MRI: machine learning-based classifications in idiopathic inflammatory myopathies.

Authors:  Keita Nagawa; Masashi Suzuki; Yuuya Yamamoto; Kaiji Inoue; Eito Kozawa; Toshihide Mimura; Koichiro Nakamura; Makoto Nagata; Mamoru Niitsu
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.